Respiratorius AB (FRA:HF00) OCF Yield %: -13.29 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HF00 Respiratorius AB FRA:HF00
34 GF Score
Price €0.27
View Full Analysis

What is Respiratorius AB OCF Yield %?

Respiratorius AB FRA:HF00 34 OCF Yield % is -13.29 as of Jul. 14, 2026. GuruFocus rates FRA:HF00 with a GF Score™ of 34/100. Among 1,410 Biotechnology companies, Respiratorius AB ranks worse than 60.92% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Respiratorius AB's Trailing 12-Month Cash Flow from Operations is €-0.31 Mil, and Market Cap is €2.14 Mil. Therefore, Respiratorius AB's OCF Yield % for today is -13.29%.

The historical rank and industry rank for Respiratorius AB's OCF Yield % or its related term are showing as below:

FRA:HF00' s OCF Yield % Range Over the Past 10 Years
Min: -32.6   Med: -20.6   Max: -10.68
Current: -13.29


During the past 13 years, the highest OCF Yield % of Respiratorius AB was -10.68%. The lowest was -32.60%. And the median was -20.60%.

FRA:HF00's OCF Yield % is ranked worse than
60.92% of 1410 companies
in the Biotechnology industry
Industry Median: -8.34 vs FRA:HF00: -13.29

Respiratorius AB's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Respiratorius AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Respiratorius AB OCF Yield % Related Terms


Respiratorius AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB OCF Yield % Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -6.52 -12.65 -27.73

Respiratorius AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.99 -11.91 -10.97 -19.00 -61.71

FRA:HF00 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Respiratorius AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Respiratorius AB OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's OCF Yield % falls into.


FRA:HF00
34GF Score
Respiratorius AB FRA:HF00
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Respiratorius AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-0.286 / 1.0313415
=-27.73%

Respiratorius AB's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.119 * 4 / 0.7713328
=-61.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -13.29 mean?
Respiratorius AB (FRA:HF00) has a OCF Yield % of -13.29 as of Jul. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Respiratorius AB and its competitors. According to the industry distribution chart, Respiratorius AB ranks #859 out of 1410 companies in the Biotechnology industry, placing it in the top 60.9%.
Is Respiratorius AB's OCF Yield % too high?
Respiratorius AB's current OCF Yield % is -13.29. Based on the distribution chart, Respiratorius AB ranks #859 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Respiratorius AB has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Respiratorius AB's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Respiratorius AB ranks #859 out of 1410 companies for OCF Yield %. This places Respiratorius AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Respiratorius AB and its competitors. Respiratorius AB's current OCF Yield % is -13.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Respiratorius AB stock overvalued right now?
Respiratorius AB (FRA:HF00) has a current OCF Yield % of -13.29. The current OCF Yield % is -13.29. Respiratorius AB's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Respiratorius AB (FRA:HF00), the current OCF Yield % is -13.29 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Respiratorius AB Business Description

Other Exchanges RESP:Sweden
Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
34GF Score

Get the complete analysis for FRA:HF00

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price